Dual inhibition of the TrkA and JAK2 pathways using entrectinib and pacritinib suppresses the growth and metastasis of HER2-positive and triple-negative breast cancers
Angelina T. Regua, Shivani Bindal, Mariana K. Najjar, Chuling Zhuang, Munazza S. Khan, Austin Arrigo, Anneliese Gonzalez, Xinhai R. Zhang, Jay‐Jiguang Zhu, Kounosuke Watabe, Hui‐Wen Lo
Topics & Concepts
Breast cancerMedicineCancer researchTriple-negative breast cancerCancerInternal medicineHER2/EGFR in Cancer ResearchCytokine Signaling Pathways and InteractionsLung Cancer Treatments and Mutations